- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 23-12-2025: Press Release
23-12-2025 | 06:28 pm
23-12-2025 | 06:28 pm
Zydus partnered with Bioeq for US commercialization rights of NUFYMCO®, an FDA-approved interchangeable biosimilar to Lucentis®. This expands Zydus' US biosimilar portfolio in an ~US$21 Cr market opportunity.
No comments yet. Be the first to comment!